Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Page logo
Latest News

Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference
Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference

UPDATE: Due to scheduling conflicts, we were unable to participate in this year’s conference.

New Brunswick, NJ (October 3rd, 2022) -- Johnson & Johnson (NYSE: JNJ) will participate in the Credit Suisse 31st Annual Global Healthcare Conference on Thursday, November 10th, 2022 at the Terranea Resort in Rancho Palos Verdes, CA. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 12:50 p.m. (Eastern Time).

This audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48 hours after the live webcast.

  • Press Contact:
    Linda Fedow
    (732) 524-6071

    Investor Contact: 
    Raychel Kruper
    732) 524-6164
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Close cookie banner icon
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue